# Integrated In Vivo and In Vitro Evaluation of a Powder-to-Hydrogel, Film-Forming Polymer Complex Base with Tissue-Protective and Microbiome-Supportive Properties

**Authors:** Daniel Banov, Guiyun Song, Zahraa Foraida, Oksana Tkachova, Oleksandr Zdoryk, Maria Carvalho

PMC · DOI: 10.3390/gels10070447 · Gels · 2024-07-05

## TL;DR

A new hydrogel-based polymer complex was tested for wound healing and microbiome support, showing better performance than a common alternative.

## Contribution

A novel powder-to-hydrogel polymer complex with tissue-protective and microbiome-supportive properties was developed and evaluated.

## Key findings

- The polymer complex enhanced cell migration and was non-cytotoxic in vitro.
- In vivo, it improved wound healing and reduced inflammation in diabetic mice.
- The complex supported favorable microbiome shifts in wound sites.

## Abstract

The study aimed to perform a comprehensive in vitro and in vivo evaluation of a newly developed, patent-pending, powder-to-hydrogel, film-forming polymer complex base, which possesses tissue-protective and microbiome-supportive properties, and to compare its characteristics with poloxamer 407. The study used a combination of in vitro assays, including tissue viability and cell migration, and in vivo wound healing evaluations in male diabetic mice. Microbiome dynamics at wound sites were also analyzed. The in vitro assays demonstrated that the polymer complex base was non-cytotoxic and that it enhanced cell migration over poloxamer 407. In vivo, the polymer complex base demonstrated superior wound healing capabilities, particularly in combination with misoprostol and phenytoin, as evidenced by the reduced wound area and inflammation scores. Microbiome analysis revealed favorable shifts in bacterial populations associated with the polymer complex base-treated wounds. The polymer complex base demonstrates clinical significance in wound care, potentially offering improved healing, safety and microbiome support. Its transformative properties and efficacy in drug delivery make it a promising candidate for advanced wound care applications, particularly in chronic wound management.

## Linked entities

- **Chemicals:** misoprostol (PubChem CID 5282381), phenytoin (PubChem CID 1775)
- **Diseases:** diabetes (MONDO:0005015)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Diseases:** cytotoxic (MESH:D064420), diabetic (MESH:D003920), inflammation (MESH:D007249)
- **Chemicals:** phenytoin (MESH:D010672), Polymer (MESH:D011108), misoprostol (MESH:D016595), poloxamer 407 (MESH:D020442)
- **Species:** Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11276563/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11276563/full.md

## References

42 references — full list in the complete paper: https://tomesphere.com/paper/PMC11276563/full.md

---
Source: https://tomesphere.com/paper/PMC11276563